期刊文献+

丙型肝炎病毒核心抗原检测对HCV感染诊断的意义 被引量:6

The significance of hepatitis C virus core antigen detection for HCV infection diagnosis
下载PDF
导出
摘要 目的探讨丙型肝炎病毒核心抗原(HCV-cAg)检测对丙型肝炎病毒(HCV)感染诊断的价值。方法随机选取于该院检验科做HCV抗体(HCV-Ab)检测的215例血液标本,采用试剂盒进行检测,首先检测HCV-Ab,根据HCV-Ab检测结果分为HCV-Ab阳性组和HCV-Ab阴性组。同时检测两组的游离HCV-cAg、总HCV-cAg、HCV-RNA。结果 HCV-Ab阳性组(97例)中,游离HCV-cAg阳性占25.8%(25/97),总HCV-cAg阳性占71.1%(69/97),HCV-RNA阳性占68.4%(66/97);HCV-Ab阴性标本组(118例)中,游离HCV-cAg阳性占1.7%(2/118),总HCV-cAg阳性占2.5%(3/118),HCV-RNA阳性占1.7%(2/118)。结论 HCV-cAg的检测有利于HCV感染的早期诊断。 Objective To investigate the value of the hepatitis C virus core antigen(HCV-cAg) detection for the diagnosis of hepatitis C virus(HCV) infection. Methods 215 cases of hepatitis C antibody(HCV-Ab) test specimen in the hospital were collected for the study. Test kits were used to detect HCV-Ab firstly,then the specimen were divided into HCV-Ab positive group and negative group,for which free HCV-cAg,total HCV-cAg, HCV-RNA were detected at the same time. Results There were 97 cases of HCV-Ab positive, free HCV-cAg positive accounted for 25. 8% (25/97), the total HCV-cAg positive 71. 1% (69/97), HCV-RNA positive 68.4% (66/97) ;there were 118 cases of HCV-Ab negative, free HCV-cAg positive accounted for 1. 7 %(2/ 118) ,the total HCV-cAg positive 2.5%(3/118),HCV-RNA positive 1.7%(2/118). Conclusion HCV-cAg test is useful for early diagnosis of HCV infection.
出处 《国际检验医学杂志》 CAS 2013年第15期1928-1929,共2页 International Journal of Laboratory Medicine
关键词 肝炎 丙型 肝炎抗体 丙型 肝炎抗原 丙型 hepatitis C hepatitis C antibodies hepatitis C antigens
  • 相关文献

参考文献11

二级参考文献29

共引文献87

同被引文献64

  • 1廖远泉.PIVKA-Ⅱ检验诊断肝细胞癌的临床应用(日文译文)[J].临床检验杂志(电子版),2012,1(2):116-118. 被引量:5
  • 2廖远泉.丙型肝炎病毒感染致病机制的研究进展[J].临床检验杂志(电子版),2012,1(4):216-220. 被引量:3
  • 3姚仁南,陈复兴,陈玲,蔡信海,王永方,陈娜云,赵飞.应用化学发光免疫分析法检测HCV抗体与其他方法的比较[J].临床输血与检验,2011,13(3):200-202. 被引量:4
  • 4魏来,管文莉,饶慧瑛,杜绍财,祁自柏,任英蓉.丙型肝炎病毒抗体诊断试剂盒(EIAgen HCV Ab Kit)的可信度分析[J].检验医学,2006,21(B10):2-7. 被引量:3
  • 5Gale Mjr, Foy EM. Evasion of intracellular host defence by hepatitis C virus [ J ]. Nature,2005,436 ( 18 ) :939 - 945.
  • 6Hezode C, Forestier N, Dusheiko G, et al. Telaprevir and peginterferon withoutribavirin for chronic HCV infection [ J ]. N Engl J Med,2009 ,360( 30 ) :1839 - 1850.
  • 7Irshad M, Dhar I, Hepatitis C virus core protein an update on its molecular biology. Cellular functions and clinical implications [J]. Med Princ Pract ,2006 ,15 ( 6 ) :405 -416.
  • 8Moratorio G, Martinez M, Gutierrez MF, et al. Evolution of naturally occurring 5' non-coding region variants of hepatitis C virus in human populations of the South American region [ J ]. Virol J,2007,4( 1 ) :79 -85.
  • 9Alter MJ, Kuhnert WL, Finelli L, et al. Guidelines for laboratory, testing and result reporting of antibody to hepatitis C vints Centers for Disease Control and Prevention [ J ]. MMWR RecommRep ,2003,52 ( RR-3 ) : 1 - 13,15.
  • 10Bowser CS, Kaye J, Leier TU, et al. Prevalence of viral and fnycobacterial co-infections in perinatally HIV-infected children [ J ]. Fetal Pediatr Pathol,2006,25 (6) : 321 - 331.

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部